Show simple item record

dc.creatorZhang, Junping
dc.creatorGuo, Ping
dc.creatorYu, Xiangping
dc.creatorFrabutt, Dylan A.
dc.creatorLam, Anh K.
dc.creatorMulcrone, Patrick L.
dc.creatorChrzanowski, Matthew
dc.creatorFirrman, Jenni
dc.creatorPouchnik, Derek
dc.creatorSang, Nianli
dc.creatorDiao, Yong
dc.creatorHerzog, Roland W.
dc.creatorXiao, Weidong
dc.date.accessioned2024-03-13T20:23:58Z
dc.date.available2024-03-13T20:23:58Z
dc.date.issued2022-09-05
dc.identifier.citationJunping Zhang, Ping Guo, Xiangping Yu, Dylan A. Frabutt, Anh K. Lam, Patrick L. Mulcrone, Matthew Chrzanowski, Jenni Firrman, Derek Pouchnik, Nianli Sang, Yong Diao, Roland W. Herzog, Weidong Xiao, Subgenomic particles in rAAV vectors result from DNA lesion/break and non-homologous end joining of vector genomes, Molecular Therapy - Nucleic Acids, Volume 29, 2022, Pages 852-861, ISSN 2162-2531, https://doi.org/10.1016/j.omtn.2022.08.027.
dc.identifier.issn2162-2531
dc.identifier.urihttp://hdl.handle.net/20.500.12613/9889
dc.description.abstractRecombinant adeno-associated virus (rAAV) vectors have been developed for therapeutic treatment of genetic diseases. Current rAAV vectors administered to affected individuals often contain vector DNA-related contaminants. Here we present a thorough molecular analysis of the configuration of non-standard AAV genomes generated during rAAV production using single-molecule sequencing. In addition to the sub-vector genomic-size particles containing incomplete AAV genomes, our results showed that rAAV preparations were contaminated with multiple categories of subgenomic particles with a snapback genome (SBG) configuration or a vector genome with deletions. Through CRISPR and nuclease-based modeling in tissue culture cells, we identified that a potential mechanism leading to formation of non-canonical genome particles occurred through non-homologous end joining of fragmented vector genomes caused by genome lesions or DNA breaks present in the host cells. The results of this study advance our understanding of AAV vectors and provide new clues for improving vector efficiency and safety profiles for use in human gene therapy.
dc.format.extent10 pages
dc.languageEnglish
dc.language.isoeng
dc.relation.ispartofFaculty/ Researcher Works
dc.relation.haspartMolecular Therapy - Nucleic Acids, Vol. 29
dc.relation.isreferencedbyCell Press
dc.rightsAttribution-NonCommercial-NoDerivs CC BY-NC-ND
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectOligonucleotides
dc.subjectTherapies and Applications
dc.subjectRecombinant adeno-associated virus (rAAV) vectors
dc.subjectSubgenomic particles
dc.subjectDNA lesion/break
dc.subjectNon-homologous end joining
dc.subjectSnapback genomes
dc.titleSubgenomic particles in rAAV vectors result from DNA lesion/break and non-homologous end joining of vector genomes
dc.typeText
dc.type.genreJournal article
dc.relation.doihttp://dx.doi.org/10.1016/j.omtn.2022.08.027
dc.ada.noteFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
dc.description.schoolcollegeLewis Katz School of Medicine
dc.creator.orcidChrzanowski|0000-0001-6161-2084
dc.temple.creatorChrzanowski, Matthew
refterms.dateFOA2024-03-13T20:23:58Z


Files in this item

Thumbnail
Name:
ChrzanowskiEtAl-JournalArticle ...
Size:
2.207Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs CC BY-NC-ND
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs CC BY-NC-ND